Apr 27, 2019 · Epinephrine-secreting pheochromocytomas may be more likely to induce glucose intolerance or frank diabetes mellitus by the preferential affinity ...
Missing: lipids | Show results with:lipids
People also ask
What labs are elevated in pheochromocytoma?
What is the hallmark of pheochromocytoma?
How does catecholamine increase blood glucose?
What is increased in pheochromocytoma?
Nov 26, 2020 · Clinical studies revealed patients with phaeochromocytoma had impaired insulin secretion as well as increased insulin resistance. Furthermore, ...
Sep 20, 2023 · Therefore, autonomous catecholamine excess in secretory PPGLs leads to clinical presentations of hypertension, tachycardia, and hyperglycemia.
Objective: This paper reviews the physiologic mechanisms responsible for glucose intolerance and diabetes mellitus in patients with pheochromocytoma.
Jul 16, 2018 · There is ample clinical evidence that glucose and lipid metabolism are compromised in PPGL patients and it is prudent to speculate that ...
Oct 13, 2016 · In contrast, a majority of cancer cells exhibit an altered glucose metabolism—they switch to glycolysis even in the abundance of oxygen (8, 25– ...
Multiple clinical studies have found that more than half of the patients with pheochromocytoma suffered from glucose metabolic disorder and even diabetes ( ...
Pheochromocytoma and Paraganglioma ... glucose and fatty acids for energy expenditure (6) ... Case 214: Adrenal pheochromocytoma with perirenal brown fat stimulation.
Dec 28, 2023 · Blood biochemistry, including sodium, potassium, creatinine, total cholesterol, LDL (low-density lipoprotein) cholesterol, HDL (high-density ...
Positive correlations between fasting glucose and plasma metanephrine ( ) and normetanephrine levels ( ) were also found.
Pheochromocytoma-Paraganglioma ... FDG is a glucose analog that becomes trapped within cells. ... Cystic and rare microscopic fat-containing pheochromocytomas ...
Mar 18, 2022 · Pheochromocytomas (PCC) and paragangliomas (PGL) are catecholamine-producing neuroendocrine tumors. According to the World Health Organization ...
The aim was to evaluate the relationship between plasma FGF-21, energy, lipid and glucose metabolism in patients with pheochromocytoma/functional paraganglioma ...
Overproduction of catecholamine induces not only hypertension but also glucose intolerance and hyperlipidemia. However, little is known about its effect on ...
Mar 2, 2022 · Glucose and fatty acids (FA) are taken up by the brown and beige adipocytes, and the uncoupling protein 1 (UCP1), a marker of BAT, uncouples the ...
Sep 17, 2019 · Catecholamine excess in patients with pheochromocytomas or paragangliomas (PPGLs) can lead to hypertension, diabetes and hyperlipidemia.
CT and MRI findings are the best guide to the management of adrenal incidentaloma (25). The lipid-rich nature of cortical adenomas is helpful in differentiating ...
Vasoactive intestinal peptide inhibits insulin-stimulated glucose transport in rat adipocytes. Am J Physiol. 1985; 249: E608-E613. View in Article. PubMed ...
Hypertension is most common, but glucose intolerance is also found in 25–75% of patients with pheochromocytoma [3, 4]. The causes of glucose intolerance in ...
Hyperglycemia: Catecholamines prevent the secretion of insulin – a hormone responsible for lowering the body's blood glucose (sugar). · Hypoglycemia: After the ...
PURPOSE: To assess the sensitivity of positron emission tomography (PET) with 2-[fluorine-18]fluoro-2-deoxy-d-glucose (FDG) in pheochromocytomas and, ...
... lipid, blood glucose and blood pressure in patients with pheochromocytoma (PCC) and paraganglioma (PGL) (collectively called PPGL). Methods The clinical ...
Jan 10, 2024 · PPGLs represent hypermetabolic states, in which adrenaline and noradrenaline induce insulin resistance in target tissues characterized by ...
subcutaneous fat mass in patients with pheochromocytoma | Overproduction of catecholamine induces not only hypertension but also glucose intolerance and
free fatty acids in pheochromocytoma, the clinical ... Effect of adrenergic blockade on glucose and fatty-acid ... and incorporation into neutral lipids by skeletal ...
Feb 25, 2024 · This has a regulatory function by increasing the number of brown fat cells, lipolysis, glucose transport, and uncoupling protein-1 (UCP-1) ...
Related searches
Related conditions
For informational purposes only. Consult your local medical authority for advice.